MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

GSK

  • Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market
    GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.
    December 29, 2023BY Naveen Athrappully
  • FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    A committee of outside advisers to the U.S. Food and Drug Administration (FDA) recommended a vaccine from GlaxoSmithKline (GSK) ...
    March 2, 2023BY Mimi Nguyen Ly
  • GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback
    Britain's GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in the ...
    November 11, 2022BY Reuters
  • GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall
    GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was ...
    November 7, 2022BY Reuters
  • GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Says FDA Approves Kidney Disease Drug for Children
    GSK Plc. said on Wednesday the Food and Drug Administration (FDA) had cleared its kidney disease drug Benlysta ...
    July 29, 2022BY Reuters
  • Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off
    LONDON—Pfizer plans to exit its 32 percent stake in Haleon, a consumer health joint venture with British drugmaker ...
    June 1, 2022BY Reuters
  • GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines ...
    February 3, 2022BY Reuters
  • GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets
    GlaxoSmithKline on Saturday said it had rejected a 50-billion-pound offer from Unilever for its consumer goods arm, saying ...
    January 18, 2022BY Reuters
  • Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO
    The head of a medical supplies company involved in the distribution and supply of monoclonal antibodies across southeastern ...
    January 13, 2022BY Tammy Hung
  • GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi
    GlaxoSmithKline PLC (GSK) said on Tuesday it would develop an HIV treatment with Japan's Shionogi for use in ...
    September 28, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss authorities have agreed to extradite a Chinese researcher to the United States, where he is accused of ...
    July 17, 2019BY Frank Fang
  • Drugmaker GSK to Eliminate 650 US Jobs
    Drugmaker GSK to Eliminate 650 US Jobs
    British drugmaker GlaxoSmithKline Plc said on Sept. 5 it would cut about 650 positions in the United States ...
    September 5, 2018BY Reuters
  • British Private Eye in China Prosecuted for Knowing Too Much
    British Private Eye in China Prosecuted for Knowing Too Much
    A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information ...
    July 14, 2014BY Matthew Robertson
TOP NEWS
  • FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
    2hr By Kimberly Hayek
    FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
  • Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
    3hr By Travis Gillmore
    Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
  • 124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
    4hr By Arthur Zhang
    124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
  • Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
    4hr By Epoch Video
    Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    4hr By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    5hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    6hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
  • House Passes Congressional Stock Trading Ban
    6hr By Jackson Richman and Nathan Worcester
    House Passes Congressional Stock Trading Ban
  • US Signs Nuclear Cooperation Deal With Saudi Arabia
    6hr By Emel Akan
    US Signs Nuclear Cooperation Deal With Saudi Arabia
  • Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
    6hr By Jack Phillips
    Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top